Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.51 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.51 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17901029 | 1.00 | LMNA (0.72) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL16673235 | 0.86 | LMNA (0.56) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL11548487 | 0.85 | L3MBTL1 (0.63) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL18562096 | 0.85 | LMNA (0.63) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL5205374 | 0.85 | LMNA (0.63) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL9857703 | 0.85 | LMNA (0.63) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL9063261 | 0.85 | LMNA (0.63) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL25437242 | 0.85 | LMNA (0.55) | LMNAL3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL9367416 | 0.85 | LMNA (1.00) | LMNAL3MBTL1ALDH1A1MAPT | |
| SCHEMBL9621415 | 0.85 | LMNA (1.00) | LMNAL3MBTL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109362781-B | Bactericide for net cage culture of whitmania pigra | 浙江海洋大学 | 2020-10-16 | — | — | CN | claimed |
| CN-102558087-A | Method for combining high quality fenoxaprop-p-ethyl | JIANGSU TIANRONG GROUP CO LTD | 2012-07-11 | — | — | CN | claimed |
| CN-119684070-A | HFIP power assisting C (sp3) Direct methylation method of-H bond and application thereof | 西南大学 | 2025-03-25 | — | — | CN | disclosed |
| CN-117645540-A | Preparation method of chlorophenoxycarboxylate | 山东润博生物科技有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117362166-A | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 上海筑裕新材料科技有限公司 | 2024-01-09 | — | — | CN | disclosed |
| EP-3490705-B1 | CATALYSTS FOR MAKING ACRYLIC ACID FROM LACTIC ACID OR ITS DERIVATIVES IN LIQUID PHASE | PROCTER & GAMBLE (US) | 2023-08-30 | — | — | EP | disclosed |
| US-20220204455-A1 | A PROCESS FOR THE SYNTHESIS OF LOFEXIDINE | PROCOS S.P.A. (IT) | 2022-06-30 | — | — | US | disclosed |
| CN-109415290-B | Method for producing acrylic acid from lactic acid or derivatives thereof in liquid phase | 宝洁公司 | 2022-03-08 | — | — | CN | disclosed |
| CN-109475848-B | Catalyst for preparing acrylic acid from lactic acid or its derivative in liquid phase | 宝洁公司 | 2021-11-19 | — | — | CN | disclosed |
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | SHANDONG RAINBOW BIOTECH CO., LTD. (CN) | 2021-08-03 | — | — | US | disclosed |
| US-11034641-B2 | Methods of making acrylic acid from lactic acid or its derivatives in liquid phase | THE PROCTER & GAMBLE COMPANY (US) | 2021-06-15 | — | — | US | disclosed |
| EP-1026149-A1 | AMIDOCARBOXYLIC ACID DERIVATIVES | Sankyo Company Limited (JP) | 2000-08-09 | — | — | EP | disclosed |
| US-5900485-A | Methods for the manufacture of neofazodone | APOTEX, INC. (CA) | 1999-05-04 | — | — | US | disclosed |
| EP-0712388-A1 | USE OF PHENOLS AND PHENOL DERIVATES AS MEDICAMENTS WITH FIBRINOGEN-REDUCING EFFECT | Roche Diagnostics GmbH (DE) | 1996-05-22 | — | — | EP | disclosed |
| WO-1995005358-A1 | USE OF PHENOLS AND PHENOL DERIVATES AS MEDICAMENTS WITH FIBRINOGEN-REDUCING EFFECT | BOEHRINGER MANNHEIM GMBH (DE) | 1995-02-23 | — | — | WO | disclosed |
| CN-1017428-B | HETEROCYCLIC COMPOUNDS | ICI PLC (GB) | 1992-07-15 | — | — | CN | disclosed |
| EP-0077662-B1 | PREPARATION OF NITROARYLACETIC ACID ESTERS AND DERIVATIVES THEREOF | ETHYL CORPORATION (US) | 1985-10-02 | — | — | EP | disclosed |
| EP-0077662-A1 | Preparation of nitroarylacetic acid esters and derivatives thereof | ETHYL CORPORATION (US) | 1983-04-27 | — | — | EP | disclosed |
| US-4169720-A | 2-[4-(4-Chlorophenoxymethyl)-phenoxy]-propionic acid compounds as herbicides | CELAMERCK GMBH & CO. KG (DE) | 1979-10-02 | — | — | US | disclosed |
| US-4105790-A | ANTICOAGULANTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | CBLB, CBL, CBLC | LMNA 2077/4885L3MBTL1 754/4885ALDH1A1 1381/4885 |
| US-20220204455-A1 | A PROCESS FOR THE SYNTHESIS OF LOFEXIDINE | LOX, SLC6A9, CYP2C9 | LMNA 3061/4885L3MBTL1 3689/4885ALDH1A1 1927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.